These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17868255)

  • 1. No association of KIR genes with Behcet's disease.
    Middleton D; Meenagh A; Sleator C; Gourraud PA; Ayna T; Tozkir H; Köse AA; Azizleri G; Diler AS
    Tissue Antigens; 2007 Nov; 70(5):435-8. PubMed ID: 17868255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A weak association of HLA-B*2702 with Behçet's disease.
    Gül A; Uyar FA; Inanç M; Ocal L; Barrett JH; Aral O; Koniçe M; Saruhan-Direskeneli G
    Genes Immun; 2002 Sep; 3(6):368-72. PubMed ID: 12209364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behçet's‎ disease.
    Mohammad-Ebrahim H; Kamali-Sarvestani E; Mahmoudi M; Beigy M; Karami J; Ahmadzadeh N; Shahram F
    Scand J Rheumatol; 2018 Mar; 47(2):155-163. PubMed ID: 28862099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis.
    Kötter I; Vonthein R; Müller CA; Günaydin I; Zierhut M; Stübiger N
    J Rheumatol; 2004 Jan; 31(1):133-9. PubMed ID: 14705232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
    García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
    Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
    Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights of HLA class I association to Behçet's disease in Portuguese patients.
    Bettencourt A; Pereira C; Carvalho L; Carvalho C; Patto JV; Bastos M; Silva AM; Barros R; Vasconcelos C; Paiva P; Costa L; Costa PP; Mendonça D; Correia J; Silva BM
    Tissue Antigens; 2008 Oct; 72(4):379-82. PubMed ID: 18627572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in Behçet's disease.
    Cavaco S; da Silva AM; Pinto P; Coutinho E; Santos E; Bettencourt A; Pinto C; Gonçalves A; Silva S; Gomes F; Carvalho L; Pereira C; Martins B; Correia J; Vasconcelos C
    Ann N Y Acad Sci; 2009 Sep; 1173():217-26. PubMed ID: 19758154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIR genes and HLA class I ligands in Gaucher disease.
    Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
    Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fae I; Fischer GF; Kouba M; Pohlreich D; Kalhs P; Greinix HT
    Bone Marrow Transplant; 2009 Jul; 44(2):97-103. PubMed ID: 19169284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.